May 28, 2009 — A new science advisory from the American Heart Association (AHA)/American Stroke Association (ASA) has given the green light to the use of tissue plasminogen activator (tPA) to treat ...

Adult patients with sickle cell disease (SCD) who experience a stroke caused by a clot (i.e., ischemic strokes or IS) can be treated safely with tissue plasminogen activator (tPA) if they qualify, ...

In the largest report on acute stroke in sickle cell disease to date, researchers at the Medical University of South Carolina and elsewhere provide the first systemic evidence for the safe use of tPA ...

Intravenous recombinant tissue plasminogen activator can be used for the treatment of acute ischemic stroke in the elderly (age ≥80 years) within the NINDS rtPA protocol The study was a prospective ...

Tissue plasminogen activator (TPA) can effectively treat patients with acute ischemic stroke, but only if administered within 3 h of stroke onset. This is not always feasible, because patients often ...

Among patients presenting directly to a thrombectomy-equipped center with a large-vessel ischemic stroke, going directly to the endovascular suite and forgoing initial IV thrombolytic therapy provides ...

HONOLULU — Extending the time window for thrombolytic therapy to 9 hours for patients selected using automated computed tomography (CT) perfusion imaging can result in excellent functional outcomes, ...

Northampton’s Cooley Dickinson Hospital reported 75 percent of eligible patients received the drug. But at Holyoke Medical Center, 96.3 percent of eligible patients -- 26 of 27 -- got the medication ...

Patients suffering from a stroke are more likely to have improved outcomes and fewer complications when hospitals use standardized guidelines for stroke care during a patient’s admission and discharge ...

Ophthalmologists at New York Eye and Ear Infirmary of Mount Sinai (NYEE) have created a novel protocol to rapidly diagnose eye stroke and expedite care to prevent irreversible vision loss. Their study ...

(UPDATED) For patients with acute ischemic strokes caused by large-vessel occlusions, forgoing IV thrombolytics before mechanical thrombectomy may be a viable option, according to the results of two ...